Nuclear Medicine Market to Surge at a Robust Pace by 2024 Prominent Players like Cardinal Health, Medtronic, Minimally Invasive Therapies, Bayer AG

Targeted therapies are majorly used as standalone therapies for treating cancer. However, these therapies can also be used in combination with chemotherapy. The early and effective diagnosis and treatment of cancer plays a significant role in improving the survival rate for cancer patients. Current treatment options, such as chemotherapy and surgery, can have adverse reactions such as the mutation of healthy/noncancerous cells.

Some of the key participants in global market are Cardinal Health, Inc., Medtronic, Minimally Invasive Therapies, Ion Beam Applications S.A (IBA Worldwide), Lantheus Medical Imaging Inc., General Electric Company, Bracco Imaging S.p.A, Bayer AG, Advanced Medical Isotope Corporation, Alliance Medical Limited, Alseres Pharmaceuticals, Inc., Avid Radiopharmaceuticals, Inc., Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Jubilant Pharma LLC, Mallinckrodt Pharmaceuticals, Medi-Radiopharma Co., Ltd., Peregrine Pharmaceuticals, Inc.,Positron Corporation and Nordion (Canada) Inc. amongst others.

Request For Sample Copy of This Report:

https://www.absolutemarketsinsights.com/request_sample.php?id=32

The conventional chemotherapy methods are being replaced by more convenient therapeutic radiopharmaceuticals for oncology and cancer treatment, which opens up new avenues in the radiopharmaceuticals market. Moreover, it not only helps physicians during diagnosis, but also works as a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices. Radiopharmaceuticals, also known as nuclear medicines, are used in applications such as lymphoma and bone metastasis. F-18, Tc-99, Ga-67, and I-123 are some of the nuclear medicines used in diagnostic procedures, while I-131, Ir-192, Y-90, I-125, Lu-177, and Ra-223 are used in therapeutics procedures.

Convenience of the treatment with minimally invasive techniques attracts more patients towards radiopharmaceuticals mode of treatment as compared to chemotherapy. The factors that drive the Radiopharmaceuticals Industry include increasing incidence of cardiac patients and adoption of clear imaging technique, with the help of diagnostic equipment such as PET and SPECT. The factors that restrain the growth of the market include supply shortages, logistical difficulties, and limited number of trained medical personnel.

A detailed study of the competitive landscape of the Nuclear Medicine Market has been given together with the insights of the businesses, monetary standing, trending developments, mergers & acquisitions and SWOT analysis. This analysis can provides a clear and precise plan concerning the market to the readers to require useful selections. This will benefit the report’s users, that evaluates their position in the market as well as create effective strategies in the near future.

Enquiry Before Buying This Report:
https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=32

Nuclear Medicine Market- By Product

  • Diagnostic Medicine
  • SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Medicine
  • Beta Emitters
  • Alpha Emitters
  • Brachytherapy Isotopes

Nuclear Medicine Market- By Application

  • Diagnostic Application
  • Oncology
  • Cardiology
  • Neurology
  • Others
  • Therapeutic Application
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors
  • Others

Market By Region

  • North America
    • U.S.
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC Countries
    • Southern Africa
    • Rest of Middle East and Africa
  • Latin America
    • Brazil
    • Rest of Latin America

Contact Us:

Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/

Follow Us on Social Media:
https://www.facebook.com/AbsoluteMarketsInsights/
https://twitter.com/AbsoluteMI
https://www.linkedin.com/company/absolute-markets-insights/
https://plus.google.com/117657938830005040584